At a guess the Board would not need to report operational changes to shareholders as you are seeking, they may well have to advise shareholders through an ASX announcement of a variation in future earnings as a result of a product demand. Now this can be done under either the Continuous Disclosure rules if the change is revenue is deemed material or as part of a Periodic Disclosure at the next reporting cycle.
However putting aside the Listing Rules as they are required to comply with there is nothing stopping a company from stepping up and advising the market through an announcement of changes to product profiles, product mix, supply or whatever else they consider worthy but this has not been the style of AHF since inception unless is was a spruiking opportunity and this behaviour is unlikely to change under the current Board as it was and remains a CEO matter if it is not a disclosure obligation.
Therein lies one of the fundamental problems with AHF.
- Forums
- ASX - By Stock
- Ann: Results of EGM
AHF
australian dairy nutritionals limited
Add to My Watchlist
0.00%
!
4.3¢

At a guess the Board would not need to report operational...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.96M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 4.2¢ | $4.515K | 105.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1499010 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 113636 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1499010 | 0.042 |
2 | 133486 | 0.041 |
3 | 187126 | 0.040 |
2 | 525000 | 0.039 |
1 | 100000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 113636 | 1 |
0.045 | 228402 | 2 |
0.046 | 493506 | 2 |
0.047 | 250000 | 1 |
0.048 | 250000 | 1 |
Last trade - 15.36pm 27/06/2025 (20 minute delay) ? |
Featured News
AHF (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online